Medical experts offer a comprehensive overview of the pathophysiology of hypercortisolism, detailing its impact on β-cell dysfunction and reduced insulin sensitivity, and discuss the potential role of GLP-1 treatment in managing the condition.
Surge in New GLP-1 Prescriptions Driven by Semaglutide's Popularity, Study Shows
Diabetes Dialogue: CATALYST Trial and Hypercortisolism in T2D, with John Buse, MD, PhD
Mendelian Randomization Links T1D to Increased Risk of Arthritis, MS
Diabetes Dialogue: ADA 2024 Diabetes Technology Recap
Semaglutide Can Preserve, Possibly Improve, NYHA Functional Class in Obesity-Related HFpEF
SGLT2 Inhibitor, GLP-1 RA Combination Improves Cardiovascular, Kidney Outcomes in Diabetes